Acetylcholine

British Journal of Pharmacology

Volumn 147, Issue SUPPL. 1, 2006, Pages

  Brown, David A ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Acetylcholine release; Muscarinic receptors; Nicotinic receptors

Indexed keywords

ACETYLCHOLINE; ATROPINE; CHLORIDE; CHLORISONDAMINE; DECAMETHONIUM; DIHYDRO BETA ERYTHROIDINE; HEXAMETHONIUM; MECAMYLAMINE; METHYLDOPA; MUSCARINIC M1 RECEPTOR AGONIST; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; NEUROTRANSMITTER; NICOTINIC RECEPTOR; PEMPIDINE; PENTAMETHONIUM; PENTOLONIUM TARTRATE; PHYSOSTIGMINE; SCOPOLAMINE; TETRAMETHYLAMMONIUM; TETRYLAMMONIUM; TRIMETAPHAN;

ACETYLCHOLINE RELEASE; ALZHEIMER DISEASE; CANCER; CHOLINERGIC NERVE; CHOLINERGIC TRANSMISSION; DRUG RECEPTOR BINDING; IMMUNOPATHOLOGY; NEUROMUSCULAR SYNAPSE; NEUROPATHIC PAIN; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BLOCKING; REVIEW; SCHIZOPHRENIA; SYMPATHETIC NERVE; SYNAPTIC TRANSMISSION;

ACETYLCHOLINE; ANIMALS; GREAT BRITAIN; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; NEUROTRANSMITTER AGENTS; PORTRAITS; RECEPTORS, CHOLINERGIC; SOCIETIES, SCIENTIFIC;

EID: 30444442330     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706474     Document Type: Review

References (64)

1. ADAMS, P.R. & BROWN, D.A. (1982). Synaptic inhibition of the M-current: slow excitatory post-synaptic potential mechanism in bullfrog sympathetic neurones. J. Physiol., 332, 263-272.
2. ALEXANDER, S.P.H., MATHIE, A. & PETERS, J.A. (2004). Acetylcholine (muscarinic) receptors: guide to receptors and channels. Br. J. Pharmacol., 141, S6.
3. ALLEN, T.G. & BROWN, D.A. (1996). Detection and modulation of acetylcholine release from neurites of rat basal forebrain cells in culture. J. Physiol., 492, 453-466.
4. ARMITAGE, A.K., MILTON, A.S. & MORRISON, C.F. (1966). Effects of nicotine and some nicotine-like compounds injected into the cerebral ventricles of the cat. Br. J. Pharmacol. Chemother., 27, 33-45.
5. BERRIE, C.P., BIRDSALL, N.J., HULME, E.C., KEEN, M. & STOCKTON, J.M. (1985). Solubilization and characterization of high and low affinity pirenzepine binding sites from rat cerebral cortex. Br. J. Pharmacol., 85, 697-703.
6. BIRDSALL, N.J.M., NATHANSON, N.M. & SCHWARZ, R.D. (2001). Muscarinic receptors: it's a knockout. Trends Pharmacol. Sci., 22, 215-219.
7. BONNER, T.I., BUCKLEY, N.J., YOUNG, A.C. & BRANN, M.R. (1987). Identification of a family of muscarinic acetylcholine receptor genes. Science, 237, 527-532.
8. BOWMAN, W.C. & RAND, M.J. (1961). Actions of triethylcholine on neuromuscular transmission. Br. J. Pharmacol., 17, 176-195.
9. BROWN, D.A., DOCHERTY, R.J. & HALLIWELL, J.V. (1983). Chemical transmission in the rat interpeduncular nucleus in vitro. J. Physiol., 341, 655-670.
10. BROWN, D.A., FORWARD, A. & MARSH, S.J. (1980). Antagonist discrimination between ganglionic and ileal muscarinic receptors. Br. J. Pharmacol., 71, 362-364.
11. BURGEN, A.S.V & SPERO, L. (1968). The action of acetylcholine and other drugs on the efflux of potassium and rubidium from smooth muscle of the guinea-pig intestine. Br. J. Pharmacol., 34, 99-115.
12. BURGEN, A.S.V & TERROUX, K.G. (1953). On the negative inotropic effect in the cat's auricle. J. Physiol., 120, 449-464.
13. BURNS, B.D. & PATON, W.D.M. (1951). Depolarization of the motor end-plate by decamethonium and acetylcholine. J. Physiol., 115, 41-73.
14. CAULFIELD, M.P. & BIRDSALL, N.J. (1998). International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol. Rev., 50, 279-290.
15. CLARK, A.L. & MITCHELSON, F. (1976). The inhibitory effect of gallamine on muscarinic receptors. Br. J. Pharmacol., 58, 323-331.
16. COLQUHOUN, D. (1981). How fast do drugs work? Trends Pharmacol. Sci., 2, 212-217.
17. COLQUHOUN, D., DREYER, F. & SHERIDAN, R.E. (1979). The actions of tubocurarine at the frog neuromuscular junction. J. Physiol., 293, 247-284.
18. COLQUHOUN, D., UNWIN, N., SHELLEY, C., BATTON, C. & SIVILOTTI, L.G. (2003). Nicotinic acetylcholine receptors. In: Drug Discovery and Drug Development, ed. Abrahams, D, pp. 357-405. New York: John Wiley (Burger's Medicinal Chemistry).
19. CORDERO-ERAUSQUIN, M., MARUBIO, LM., KLINK, R. & CHANGEUX, J.-P. (2000). Nicotinic receptor function: new perspectives from knockout mice. Trends Pharmacol. Sci., 21, 211-217.
20. CORNE, S.J. & EDGE, N.D. (1958). Pharmacological properties of pempidine (1:2:2:6:6-pentamethylenepiperidine), a new ganglion-blocking compound. Br. J. Pharmacol., 13, 339-349.
21. DALE, H.H. (1914). The action of certain esters and ethers of choline, and their relation to muscarine. J. Pharmacol. Exp. Ther., 6, 147-190.
22. DALE, H.H. & DUDLEY, H.W. (1929). The presence of histamine and acetylcholine in the spleen of the ox and horse. J. Physiol., 68, 97-123.
23. DANI, J.A., JI, D. & ZHOU, F.M. (2001). Synaptic plasticity and nicotine addiction. Neuron, 31, 349-352.
24. DEL CASTILLO, J. & KATZ, B. (1957). The identity of intrinsic and extrinsic acetylcholine receptors in the motor end-plate. Proc. R. Soc. London B, 146, 357-361.
25. DESCARRIES, L., GISIGER, V. & STERIADE, M. (1997). Diffuse transmission by acetylcholine in the CNS. Prog. Neurobiol., 53, 603-625.
26. ECCLES, J.C., ECCLES, D.M. & FATT, P. (1956). Pharmacological investigations on a central synapse operated by acetylcholine. J. Physiol., 131, 154-169.
27. FATT, P. & KATZ, B. (1951). An analysis of the end-plate potential recorded with an intracellular electrode. J. Physiol., 115, 320-370.
28. FATT, P. & KATZ, B. (1952). Spontaneous subthreshold activity at motor nerve endings. J. Physiol., 117, 109-128.
29. FUKUDA, K., KUBO, T., AKlBA, I., MAEDA, A., MISHINA, M. & NUMA, S. (1987). Molecular distinction between muscarinic acetylcholine receptor subtypes. Nature, 327, 623-625.
30. GAHWILER, B.H. & BROWN, D.A. (1985). Functional innervation of cultured hippocampal neurones by cholinergic afferents from co-cultured septal explants. Nature, 313, 577-579.
31. GURNEY, A.M & RANG, H.P. (1984). The channel-blocking action of methonium compounds on rat submandibular ganglion cells. Br. J. Pharmacol., 82, 623-642.
32. HAMMER, R, BERRIE, C.P., BIRDSALL, N.J., BURGEN, A.S. & HULME, E.C. (1980). Pirenzepine distinguishes between different subclasses of muscarinic receptors. Nature, 283, 90-92.
33. HANSEL, T.T. & BARNES, P.J. (2002). Tiotropium bromide: a novel once-daily anticholinergic bronchodilator for the treatment of COPD. Drugs Today (Barc.), 38, 585-600.
34. JENKINSON, D.H. (1957). The nature of the antagonism between calcium and magnesium ions at the neuromuscular junction. J. Physiol., 138, 434-444.
35. JONES, S., SUDWEEKS, S. & YAKEL, J.L. (1999). Nicotinic receptors in the brain: correlating physiology with function. Trends Neurosci., 22, 555-561.
36. KARLIN, A. (2002). Emerging structure of the nicotinic acetylcholine receptors. Nat. Rev. Neurosci., 3, 102-114.
37. LAZARENO, S. & BIRDSALL, N.J. (1995). Detection, quantitation, and verification of allosteric interactions of agents with labeled and unlabeled ligands at G protein-coupled receptors: interactions of strychnine and acetylcholine at muscarinic receptors. Mol. Pharmacol., 48, 362-378.
38. MASON, D.F.J. & WIEN, R. (1955). The actions of heterocyclic bisquaternary compounds, especially of a pyrrolidinium series. Br. J. Pharmacol., 10, 124-132.
39. MATHIE, A., CULL-CANDY, S.G. & COLQUHOUN, D. (1987). Single-channel and whole-cell currents evoked by acetylcholine in dissociated sympathetic neurons of the rat. Proc. R. Soc. London B, 232, 239-248.
40. MCCANCE, I., PHILLIS, J.W. & WESTERMAN, R.A. (1968). Acetylcholine-sensitivity of thalamic neurones: its relationship to synaptic transmission. Br. J. Pharmacol., 32, 635-651.
41. MCGEHEE, D.S., HEATH, M.J., GELBER, S., DEVAY, P. & ROLE, L.W. (1995). Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors. Science, 269, 1692-1696.
42. MCGEHEE, D.S. & ROLE, L.W. (1995). Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annu. Rev. Physiol., 51, 521-546.
43. MENTIS, G.Z., ALVAREZ, F.J., BONNOT, A., RICHARDS, D.S., GONZALEZ-FORERO, D., ZERDA, R. & O'DONOVAN, M.J. (2005). Noncholinergic excitatory actions of motoneurons in the neonatal mammalian spinal cord. Proc. Natl. Acad. Sci. U.S.A., 102, 7344-7349.
44. MICHEL, M.C. & DE LA ROSETTE, J.J. (2005). Role of muscarinic receptor antagonists in urgency and nocturia. BJU Int., 96 (Suppl 1), 37-42.
45. MITCHELL, J.F. (1963). The spontaneous and evoked release of acetylcholine from the cerebral cortex. J. Physiol., 165, 98-116.
46. NODA, M., TAKAHASHI, H., TANABE, T., TOYOSATO, M., FURUTANI, Y., HIROSE, T., ASAI, M., INAYAMA, S., MIYATA, T. & NUMA, S. (1982). Primary structure of alpha-subunit precursor of Torpedo californica acetylcholine receptor deduced from cDNA sequence. Nature, 299, 793-797.
47. NORTH, R.A. (1989). Drug receptors and the inhibition of nerve cells. Br. J. Pharmacol., 19, 13-28.
48. NORTH, R.A. & TOKIMASA, T. (1984). The time course of muscarinic depolarization of guinea-pig myenteric neurones. Br. J. Pharmacol., 82, 85-91.
49. PATON, W.D.M. & ZAIMIS, E.J. (1949). The pharmacological actions of polymethylene bistrimethyl-ammonium salts. Br. J. Pharmacol. Chemother., 4, 381-400.
50. PERALTA, E.G., WINSLOW, J.W., PETERSON, G.L., SMITH, D.H., ASHKENAZI, A., RAMACHANDRAN, J., SCHIMERLIK, M.I. & CAPON, D.J. (1987). Primary structure and biochemical properties of an M2 muscarinic receptor. Science, 236, 600-605.
51. PURVES, R.D. (1974). Muscarinic excitation: a microelectrophoretic study on cultured smooth muscle cells. Br. J. Pharmacol., 52, 77-86.
52. RANG, H.P. (1981). The characteristics of synaptic currents and responses to acetylcholine of rat submandibular ganglion cells. J. Physiol., 311, 23-55.
53. SIVILOTTI, L. & COLQUHOUN, D. (1995). Acetylcholine receptors: too many channels, too few functions. Science, 269, 1681-1682.
54. SKOK, M.V., KALASHNIK, E.N., KOVAL, L.N., TSETLIN, V.I., UTKIN, Y.N., CHANGEUX, J.-P. & GRAILHE, R. (2003). Functional nicotinic acetylcholine receptors are expressed in B lymphocyte-derived cell lines. Mol. Pharmacol., 64, 885-889.
55. SPINKS, A., YOUNG, E.H.P., FARRINGTON, J.A. & DUNLOP, D. (1958). The pharmacological actions of pempidine. Br. J. Pharmacol., 13, 501-520.
56. SUMIKAWA, K., HOUGHTON, M., SMITH, J.C., BELL, L., RICHARDS, B.M. & BARNARD, E.A. (1982). The molecular cloning and characterisation of cDNA coding for the alpha subunit of the acetylcholine receptor. Nucleic Acids Res., 10, 5809-5822.
57. SYMPOSIUM (1954). Symposium on neurohumoral transmission. Pharmacol. Rev., 6, 1-131.
58. TRENDELENBURG, A.U., MEYER, A., WESS, J. & STARKE, K. (2005). Distinct mixtures of muscarinic receptor subtypes mediate inhibition of noradrenaline release in different mouse peripheral tissues, as studied with receptor knockout mice. Br. J. Pharmacol., June 20 (Epub ahead of print).
59. UNWIN, N. (2005). Refined structure of the nicotinic acetylcholine receptor at 4 Å resolution. J. Mol. Biol., 346, 967-989.
60. VOGT, M. (1969). Release from brain tissue of compounds with possible transmitter function: interaction of drugs with these substances. Br. J. Pharmacol., 37, 325-337.
61. WESS, J. (2004). Muscarinic acetylcholine receptor knockout mice: novel phenotypes and clinical implications. Annu. Rev. Pharmacol. Toxicol., 44, 423-450.
62. WONNACOTT, S. (1997). Presynaptic nicotinic ACh receptors. Trends Neurosci., 20, 92-98.
63. ZENG, F. & WESS, J. (2000). Molecular aspects of muscarinic receptor dimerization. Neuropsychopharmacology, 23 (4 Suppl), S19-S31.
64. ZHOLOS, A.V. & BOLTON, T.B. (1997). Muscarinic receptor subtypes controlling the cationic current in guinea-pig ileal smooth muscle. Br. J. Pharmacol., 122, 885-893.